Transcarotid approach for transcatheter�aortic ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Transcarotid approach for transcatheter�aortic valve replacement with the sapien 3 prosthesis: a multicenter french registry
Auteur(s) :
Overtchouk, Pavel [Auteur]
Folliguet, Thierry [Auteur]
Pinaud, Frederic [Auteur]
Fouquet, Oliver [Auteur]
Pernot, Mathieu [Auteur]
Bonnet, Guillaume [Auteur]
Hubert, Maxime [Auteur]
Lapeze, Joel [Auteur]
Claudel, Jean-Philippe [Auteur]
Ghostine, Said [Auteur]
Azmoun, Alexandre [Auteur]
Caussin, Christophe [Auteur]
Zannis, Konstantinos [Auteur]
Harmouche, Majid [Auteur]
Verhoye, Jean-Philippe [Auteur]
Lafont, Antoine [Auteur]
Chamandi, Chekrallah [Auteur]
Ruggieri, Vito Giovanni [Auteur]
Di Cesare, Alessandro [Auteur]
Leclercq, Florence [Auteur]
Gandet, Thomas [Auteur]
Modine, Thomas [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Folliguet, Thierry [Auteur]
Pinaud, Frederic [Auteur]
Fouquet, Oliver [Auteur]
Pernot, Mathieu [Auteur]
Bonnet, Guillaume [Auteur]
Hubert, Maxime [Auteur]
Lapeze, Joel [Auteur]
Claudel, Jean-Philippe [Auteur]
Ghostine, Said [Auteur]
Azmoun, Alexandre [Auteur]
Caussin, Christophe [Auteur]
Zannis, Konstantinos [Auteur]
Harmouche, Majid [Auteur]
Verhoye, Jean-Philippe [Auteur]
Lafont, Antoine [Auteur]
Chamandi, Chekrallah [Auteur]
Ruggieri, Vito Giovanni [Auteur]
Di Cesare, Alessandro [Auteur]
Leclercq, Florence [Auteur]
Gandet, Thomas [Auteur]
Modine, Thomas [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Titre de la revue :
JACC. Cardiovascular interventions
Nom court de la revue :
JACC Cardiovasc Interv
Date de publication :
2019-02-07
ISSN :
1876-7605
Mot(s)-clé(s) en anglais :
Sapien 3
transcarotid
TAVR
transcarotid
TAVR
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
OBJECTIVE: This study sought to describe the procedural and clinical outcomes of patients undergoing transcarotid (TC) transcatheter aortic valve replacement (TAVR) with the Edwards Sapien 3 device.
BACKGROUND: The TC ...
Lire la suite >OBJECTIVE: This study sought to describe the procedural and clinical outcomes of patients undergoing transcarotid (TC) transcatheter aortic valve replacement (TAVR) with the Edwards Sapien 3 device. BACKGROUND: The TC approach for TAVR holds the potential to become the optimal alternative to the transfemoral gold standard. Limited data exist regarding safety and efficacy of TC-TAVR using the Edwards Sapien 3 device. METHODS: The French Transcarotid TAVR prospective multicenter registry included patients between 2014 and 2018. Consecutive patients treated in 1 of the 13 participating centers ineligible for transfemoral TAVR were screened for TC-TAVR. Clinical and echocardiographic data were prospectively collected. Perioperative and 30-day outcomes were reported according to the updated Valve Academic Research Consortium (VARC-2). RESULTS: A total of 314 patients were included with a median (interquartile range) age of 83 (78 to 88) years, 63% were males, Society of Thoracic Surgeons mortality risk score 5.8% (4% to 8.3%). Most patients presented with peripheral artery disease (64%). TC-TAVR was performed under general anesthesia in 91% of cases, mostly using the left carotid artery (73.6%) with a procedural success of 97%. Three annulus ruptures were reported, all resulting in patient death. At 30 days, rates of major bleeding, new permanent pacemaker, and stroke or transient ischemic attack were 4.1%, 16%, and 1.6%, respectively. The 30-day mortality was 3.2%. CONCLUSIONS: TC-TAVR using the Edwards Sapien 3 device was safe and effective in this prospective multicenter registry. The TC approach might be considered, in selected patients, as the first-line alternative approach for TAVR whenever the transfemoral access is prohibited. Sapien 3 device was safe and effective in our multicenter cohort.Lire moins >
Lire la suite >OBJECTIVE: This study sought to describe the procedural and clinical outcomes of patients undergoing transcarotid (TC) transcatheter aortic valve replacement (TAVR) with the Edwards Sapien 3 device. BACKGROUND: The TC approach for TAVR holds the potential to become the optimal alternative to the transfemoral gold standard. Limited data exist regarding safety and efficacy of TC-TAVR using the Edwards Sapien 3 device. METHODS: The French Transcarotid TAVR prospective multicenter registry included patients between 2014 and 2018. Consecutive patients treated in 1 of the 13 participating centers ineligible for transfemoral TAVR were screened for TC-TAVR. Clinical and echocardiographic data were prospectively collected. Perioperative and 30-day outcomes were reported according to the updated Valve Academic Research Consortium (VARC-2). RESULTS: A total of 314 patients were included with a median (interquartile range) age of 83 (78 to 88) years, 63% were males, Society of Thoracic Surgeons mortality risk score 5.8% (4% to 8.3%). Most patients presented with peripheral artery disease (64%). TC-TAVR was performed under general anesthesia in 91% of cases, mostly using the left carotid artery (73.6%) with a procedural success of 97%. Three annulus ruptures were reported, all resulting in patient death. At 30 days, rates of major bleeding, new permanent pacemaker, and stroke or transient ischemic attack were 4.1%, 16%, and 1.6%, respectively. The 30-day mortality was 3.2%. CONCLUSIONS: TC-TAVR using the Edwards Sapien 3 device was safe and effective in this prospective multicenter registry. The TC approach might be considered, in selected patients, as the first-line alternative approach for TAVR whenever the transfemoral access is prohibited. Sapien 3 device was safe and effective in our multicenter cohort.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Équipe(s) de recherche :
Troubles cognitifs dégénératifs et vasculaires
Date de dépôt :
2019-11-27T14:30:11Z